SRA's number for the day: 53
This article was originally published in SRA
Executive Summary
"In a review of Class I [medical device] recalls, in 53% of the cases firms were unable to correct or remove all of the faulty devices from the market," according to Jay Crowley, the US Food and Drug Administration's senior advisor for patient safety.